160 related articles for article (PubMed ID: 18563576)
1. Application of a four-fluid nozzle spray drier to prepare inhalable rifampicin-containing mannitol microparticles.
Mizoe T; Ozeki T; Okada H
AAPS PharmSciTech; 2008; 9(3):755-61. PubMed ID: 18563576
[TBL] [Abstract][Full Text] [Related]
2. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
3. Preparation of drug nanoparticle-containing microparticles using a 4-fluid nozzle spray drier for oral, pulmonary, and injection dosage forms.
Mizoe T; Ozeki T; Okada H
J Control Release; 2007 Sep; 122(1):10-5. PubMed ID: 17655963
[TBL] [Abstract][Full Text] [Related]
4. One-step preparation of drug-containing microparticles to enhance the dissolution and absorption of poorly water-soluble drugs using a 4-fluid nozzle spray drier.
Mizoe T; Beppu S; Ozeki T; Okada H
J Control Release; 2007 Jul; 120(3):205-10. PubMed ID: 17582644
[TBL] [Abstract][Full Text] [Related]
5. Improved bioavailability of a water-insoluble drug by inhalation of drug-containing maltosyl-β-cyclodextrin microspheres using a four-fluid nozzle spray drier.
Ozeki T; Kano Y; Takahashi N; Tagami T; Okada H
AAPS PharmSciTech; 2012 Dec; 13(4):1130-7. PubMed ID: 22945234
[TBL] [Abstract][Full Text] [Related]
6. Development of Dried Emulsion/Mannitol Composite Microparticles through a Unique Spray Nozzle for Efficient Delivery of Hydrophilic Anti-tuberculosis Drug against Alveolar Macrophages.
Maeda R; Ito T; Tagami T; Takii T; Ozeki T
Biol Pharm Bull; 2019; 42(11):1846-1853. PubMed ID: 31685768
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
Sinsuebpol C; Chatchawalsaisin J; Kulvanich P
Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397
[TBL] [Abstract][Full Text] [Related]
8. Formulating Inhalable Dry Powders Using Two-Fluid and Three-Fluid Nozzle Spray Drying.
Leng D; Thanki K; Foged C; Yang M
Pharm Res; 2018 Nov; 35(12):247. PubMed ID: 30386927
[TBL] [Abstract][Full Text] [Related]
9. Preparation of polymeric submicron particle-containing microparticles using a 4-fluid nozzle spray drier.
Ozeki T; Beppu S; Mizoe T; Takashima Y; Yuasa H; Okada H
Pharm Res; 2006 Jan; 23(1):177-83. PubMed ID: 16267631
[TBL] [Abstract][Full Text] [Related]
10. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
Pai RV; Jain RR; Bannalikar AS; Menon MD
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
[TBL] [Abstract][Full Text] [Related]
11. Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery.
Mehanna MM; Mohyeldin SM; Elgindy NA
Int J Nanomedicine; 2019; 14():9089-9112. PubMed ID: 31819421
[TBL] [Abstract][Full Text] [Related]
12. Improved intestinal absorption of a poorly water-soluble oral drug using mannitol microparticles containing a nanosolid drug dispersion.
Nishino Y; Kubota A; Kanazawa T; Takashima Y; Ozeki T; Okada H
J Pharm Sci; 2012 Nov; 101(11):4191-200. PubMed ID: 22864998
[TBL] [Abstract][Full Text] [Related]
13. Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.
Manca ML; Cassano R; Valenti D; Trombino S; Ferrarelli T; Picci N; Fadda AM; Manconi M
J Pharm Pharmacol; 2013 Sep; 65(9):1302-11. PubMed ID: 23927468
[TBL] [Abstract][Full Text] [Related]
14. Potential of aerosolized rifampicin lipospheres for modulation of pulmonary pharmacokinetics and bio-distribution.
Singh C; Koduri LV; Dhawale V; Bhatt TD; Kumar R; Grover V; Tikoo K; Suresh S
Int J Pharm; 2015 Nov; 495(2):627-32. PubMed ID: 26392246
[TBL] [Abstract][Full Text] [Related]
15. Design of Inhalable Solid Dosage Forms of Budesonide and Theophylline for Pulmonary Combination Therapy.
Leng D; Kissi EO; Löbmann K; Thanki K; Fattal E; Rades T; Foged C; Yang M
AAPS PharmSciTech; 2019 Mar; 20(3):137. PubMed ID: 30847607
[TBL] [Abstract][Full Text] [Related]
16. Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying.
Stocke NA; Meenach SA; Arnold SM; Mansour HM; Hilt JZ
Int J Pharm; 2015 Feb; 479(2):320-8. PubMed ID: 25542988
[TBL] [Abstract][Full Text] [Related]
17. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
[TBL] [Abstract][Full Text] [Related]
19. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.
Sharma R; Saxena D; Dwivedi AK; Misra A
Pharm Res; 2001 Oct; 18(10):1405-10. PubMed ID: 11697465
[TBL] [Abstract][Full Text] [Related]
20. Co-spray dried resveratrol and budesonide inhalation formulation for reducing inflammation and oxidative stress in rat alveolar macrophages.
Trotta V; Lee WH; Loo CY; Young PM; Traini D; Scalia S
Eur J Pharm Sci; 2016 Apr; 86():20-8. PubMed ID: 26944422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
